GLP-1 and Swollen Lymph Nodes: Causes and When to Seek Help Glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide, dulaglutide, and liraglutide are increasingly prescribed in the UK for type 2 diabetes and weight management
It does not provide medical advice, diagnosis, or treatment recommendations
Nausea Vomiting Diarrhea Decreased appetite Upset stomach Constipation Abdominal pain Mounjaro can also sometimes cause serious side effects such as serious, life-threatening allergic reactions (hives, swelling of the tongue or throat, and shortness of breath), inflammation of your pancreas, gallstones, increased risk of certain types of thyroid cancer, vision problems, low blood sugar levels, and kidney injury
Tirzepatide has a specific molecular weight (approximately 4,813.45 daltons), and mass spec verification ensures the product is actually tirzepatide and not a different peptide, a fragment, or a mixture
But many of the GLP-1s advertised on the internet are compounded GLP-1s, which means the drugs are made in compounding pharmacies, and the products are not approved by the FDA or regulated in the same way as the branded versions
This paper extends our current knowledge of the effectiveness of this class of medications. Weighing benefits and risks The greatest risk increases were seen for nausea and vomiting, kidney stones, gastroesophageal reflux disease or GERD, sleep disturbances and non-infectious gastroenteritis, which is inflammation of the digestive tract which can cause nausea, vomiting, diarrhea and stomach cramps